Neogen Corporation

NEOG Healthcare Medical Devices

Neogen Corporation’s revenue for fiscal 2026 (year ended May 2026) was $870.4 million, down 2.72% from fiscal 2025. In the quarter to August 2026, revenue grew 6.51%, EPS fell 132.1%, free cash flow grew 135.8% and total debt fell 2.31%, each against the same quarter a year earlier. Insiders bought in the last twelve months.

11.81 0.46 −3.75%
Market cap
$2.7B
P/E
0.0×
Fwd P/E
−36.3×
Dividend yield
—
F-score
5/9
Altman Z
1.11
Beneish M
−2.43
Dividend safety
n/a
Aug '26 May '26 Feb '26 Nov '25 Older periods
P/E ratio
0.00 0.00 0.00 0.00

+8 more quarters

P/S ratio
2.85 2.23 2.79 1.46
P/FCF ratio
50.58 60.63 385.29 0.00
P/Operating CF
195.44 64.24 106.92 66.19
P/B ratio
1.21 0.93 1.15 0.61
EV/Sales
3.56 2.95 3.54 2.22
EV/EBITDA
26.66 25.10 35.22 19.72
EV/FCF
63.05 80.24 488.90 (109.37)
Current Ratio
3.90 3.82 3.92 3.91
Net Debt/EBITDA
20.69 15.73 24.27 26.95
Debt/Equity
0.37 0.38 0.38 0.38
Earnings Yield
(2.20%) (0.34%) (25.11%) (46.79%)
Free Cash Flow Yield
1.98% 1.65% 0.26% (1.39%)
Free Cash Flow per Share
0.02 0.12 0.05 0.04
Book value per Share
9.57 9.62 9.66 9.68
Free Cash Flow
4.70 26.20 11.17 7.78
EV/EBIT
0.00 0.00 0.00 0.00
Other line items

Show all line items

Columns are period end dates · fundamentals updated 13 Oct 2026